the invention disclosed comprises novel and inventive uses of Silver Sulfadiazine, and associated preparations and combinations These include a method of treating a viral ailment, comprising the step of applying Silver Sulfadiazine proximate a site upon a person's skin where said viral ailment is manifest, using Silver Sulfadiazine to treat a viral ailment, and distributing Silver Sulfadiazine to treat a viral ailment Also disclosed is a medically-prescriptive combination for treating a viral ailment, comprising Silver Sulfadiazine, and instructions to use said Silver Sulfadiazine to treat a viral ailment Further disclosed is Silver Sulfadiazine prepared at various strengths of less than 1%, as well as preparing Silver Sulfadiazine at various strengths of less than 1% These strengths may be suitable for the viral ailments disclosed, although they are not strong enough for bacterial and fungal ailments for which Silver Sulfadiazine is ordinarily used Brief Description of the Drawings.Silver Sulfadiazine it would be desirable to treat viral ailments manifesting on a patient's skin, such as herpes, fever blisters, cold sores, Chicken Pox, and genital and other warts, in a manner as simply and effectively as Silver Sulfadiazine is used to treat burns It would also be desirable to employ Silver Sulfadiazine at a strength of less than 1%, if it can be effective at such lesser strengths against ailments for which it has not been heretofore used.Silver Sulfadiazine as a pharmaceutical product, is prepared exclusively at a strength of 1% Because pharmaceutical protocols require use of medicinal compounds at the minimum strength required to be medically effective, this means that Silver Sulfadiazine distributed at less than 1% strength would not be effective against the bacterial and fungal ailments for which it is used and there would thus be no motivation to prepare a lesser strength compound absent the discovery of some other uses not yet known in the prior art.Silver Sulfadiazine acting as a topical antibiotic, has been very effective for controlling bacterial and fungal infections following burns, by directly killing the bacteria or fungus.burn patients frequently die of infections following sever burning, rather than the burns themselves.Silver Sulfadiazine which is a broad-spectrum antimicrobial agent with bactericidal activity against most g+ and g- bacteria as well as yeast, has been used particularly for the treatment of burns.This invention of Silver Sulfadiazine combined two previously- known antibacterial agents for burns, silver nitrate and sulfadiazine, to create a synergistic compound that is extremely effective against infection.Silver Sulfadiazine chemically illustrated in Figure 1, was first patented by Charles L Fox, Jr on September 25, 1973, in U S Patent 3,761 ,590.This invention relates generally to the treatment of viral ailments manifesting through a patient's skin, and particularly, to the use of Silver Sulfadiazine to treat such ailments.sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine A61K31/635- Compounds containing para-N-benzenesulfonyl-N-groups, e.g. ![]() sulfanilamide, p-nitrobenzenesulfonyl hydrazide ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |